Todd V. Brennan

A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours

Keith Dredge, Todd V. Brennan, Edward Hammond et al. · British Journal of Cancer · 2018 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Circulating mitochondria in organ donors promote allograft rejection

Liwen Lin, He Xu, Muath Bishawi et al. · American Journal of Transplantation · 2019 · 79 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation

Todd V. Brennan, Liwen Lin, Joshua D. Brandstadter et al. · Journal of Clinical Investigation · 2015 · 65 citations · Full text

Medicine, Immunology, Oncology +17

Renal Transplant Imaging Using Magnetic Resonance Angiography With a Nonnephrotoxic Contrast Agent

Mustafa R. Bashir, Tracy A. Jaffe, Todd V. Brennan et al. · Transplantation · 2013 · 54 citations

Medicine, Nephrology, Radiology +17

Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors

Edward Hammond, Nicole M. Haynes, Carleen Cullinane et al. · Journal for ImmunoTherapy of Cancer · 2018 · 49 citations · Full text

Life Sciences, Immunology, Pharmacology +17